Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cancer treatments including administering IL-2 fusion proteins with modulated selectivity

Cancer treatments including administering IL-2 fusion proteins with modulated selectivity

US Patent 7462350 · Granted Dec 9, 2008

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-PD-L1 antibodies2025
Humanized and de-immunized antibodies2024
Anti-PD-L1 and IL-2 cytokines2024
Light chain immunoglobulin fusion proteins and methods of use thereof2022
TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in2022
Targeted TGFβ inhibition2022
Anti-CD19 antibodies with reduced immunogenicity2021
Humanized antibodies2021
SIRP-α immunoglobulin fusion proteins2021
Anti-cancer antibodies with reduced complement fixation2020
Humanized antibodies2020
Antibodies and immunocytokines2020